The Ball is in Your Court: Agenda for Research to Advance the Science of Patient Preferences in the Regulatory Review of Medical Devices in the United States
- 22 August 2017
- journal article
- review article
- Published by Springer Nature in The Patient - Patient-Centered Outcomes Research
- Vol. 10 (5) , 531-536
Abstract
No abstract availableFunding Information
- None (No funding associated with this editorial)
This publication has 10 references indexed in Scilit:
- Advancing the science of patient input throughout the regulatory decision‐making processLearning Health Systems, 2017
- Using Discrete Choice Experiments to Inform the Benefit-Risk Assessment of Medicines: Are We Ready Yet?PharmacoEconomics, 2017
- Preference for subcutaneous or intravenous administration of rituximab among patients with untreated CD20+ diffuse large B-cell lymphoma or follicular lymphoma: results from a prospective, randomized, open-label, crossover study (PrefMab)Annals of Oncology, 2017
- Giving Patients’ Preferences a Voice in Medical Treatment Life Cycle: The PREFER Public–Private ProjectThe Patient - Patient-Centered Outcomes Research, 2017
- Comparison of different approaches applied in Analytic Hierarchy Process – an example of information needs of patients with rare diseasesBMC Medical Informatics and Decision Making, 2016
- Valuing Treatments for Parkinson Disease Incorporating Process Utility: Performance of Best-Worst Scaling, Time Trade-Off, and Visual Analogue ScalesValue in Health, 2016
- Incorporating patient preferences into drug development and regulatory decision making: Results from a quantitative pilot study with cancer patients, carers, and regulatorsClinical Pharmacology & Therapeutics, 2015
- Incorporating patient-preference evidence into regulatory decision makingSurgical Endoscopy, 2015
- Caregiver Preferences for Emerging Duchenne Muscular Dystrophy Treatments: A Comparison of Best-Worst Scaling and Conjoint AnalysisThe Patient - Patient-Centered Outcomes Research, 2014
- A Community-Engaged Approach to Quantifying Caregiver Preferences for the Benefits and Risks of Emerging Therapies for Duchenne Muscular DystrophyClinical Therapeutics, 2014